Teza Capital Management LLC decreased its holdings in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) by 62.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,129 shares of the company’s stock after selling 6,900 shares during the period. Teza Capital Management LLC’s holdings in Ceridian HCM were worth $231,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently made changes to their positions in CDAY. Capital International Investors purchased a new position in shares of Ceridian HCM during the 1st quarter valued at approximately $366,250,000. Vanguard Group Inc. lifted its position in shares of Ceridian HCM by 4.1% during the 3rd quarter. Vanguard Group Inc. now owns 16,591,001 shares of the company’s stock valued at $927,105,000 after buying an additional 658,046 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Ceridian HCM by 377.0% in the 1st quarter. Renaissance Technologies LLC now owns 822,000 shares of the company’s stock valued at $56,204,000 after purchasing an additional 649,656 shares in the last quarter. Natixis lifted its holdings in Ceridian HCM by 4,343.7% in the 2nd quarter. Natixis now owns 630,968 shares of the company’s stock valued at $29,706,000 after purchasing an additional 616,769 shares in the last quarter. Finally, Woodline Partners LP purchased a new position in Ceridian HCM in the 2nd quarter valued at $26,334,000.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the company. Credit Suisse Group raised their price objective on Ceridian HCM from $90.00 to $105.00 and gave the company an “outperform” rating in a report on Thursday, February 9th. Moffett Nathanson assumed coverage on Ceridian HCM in a report on Monday, January 9th. They issued a “market perform” rating and a $68.00 price objective on the stock. Barclays raised their price objective on Ceridian HCM from $64.00 to $74.00 and gave the company an “equal weight” rating in a report on Thursday, February 9th. Cowen raised their target price on Ceridian HCM from $70.00 to $77.00 and gave the stock an “outperform” rating in a research note on Monday, November 14th. Finally, BMO Capital Markets raised their target price on Ceridian HCM from $73.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 9th. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Ceridian HCM has an average rating of “Moderate Buy” and a consensus target price of $79.64.
Insider Buying and Selling
Ceridian HCM Stock Up 0.9 %
Shares of NYSE:CDAY opened at $68.06 on Tuesday. The business has a 50-day moving average price of $71.31 and a 200 day moving average price of $65.14. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $10.49 billion, a price-to-earnings ratio of -141.79 and a beta of 1.45. Ceridian HCM Holding Inc. has a 12-month low of $43.23 and a 12-month high of $79.66.
Ceridian HCM Profile
Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.
Recommended Stories
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- First Republic: First Rate Risk or Time To Buy?
- These Hedge Funds Are Getting Crushed By SVB
- Buy The Dip In The Charles Schwab Corporation
- ZIM Integrated Shipping Services: Up 15% But Don’t Chase It
- FedEx Is A Buy Going Into Earnings
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.